MedTrace Logo

An Observational Study of Statin Treatment Induced HDL Changes

NCT01551784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120000

Last updated 2013-10-16

No results posted yet for this study

Summary

The aim with this study is to investigate the effect of statin induced changes in HDL-C on all cause mortality and CVD with adjustment for changes in other blood lipids and clinical parameters in Sweden, UK and the Netherlands.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Gunnar Johansson, MD, PROFESSOR · Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology Uppsala University 751 22 Uppsala Sweden

  • Ron Herings, DR, ASSOC PROF · Pharmo Institute for Drug Outcomes Research3508 AE UtrechtThe Netherlands

Eligibility

Min Age
18 Years
Max Age
86 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-10-31
Completion
2012-10-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01551784 on ClinicalTrials.gov